{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:13:38Z","timestamp":1787876018523,"version":"build-2784847793"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["81271163, 81470755"],"award-info":[{"award-number":["81271163, 81470755"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["81373366"],"award-info":[{"award-number":["81373366"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.nano.2015.02.015","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T16:17:22Z","timestamp":1426695442000},"page":"1109-1115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["A novel topical nano-propranolol for treatment of infantile hemangiomas"],"prefix":"10.1016","volume":"11","author":[{"given":"Zheng Gang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Lu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei En","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2015.02.015_bb0005","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1525-1470.2008.00626.x","article-title":"Infantile hemangiomas: how common are they? A systematic review of the medical literature","volume":"25","author":"Kilcline","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.nano.2015.02.015_bb0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.47102\/annals-acadmedsg.V42N5p253","article-title":"Use of propranolol for treatment of large infantile haemangiomas\u2014a report of two cases and review of the literature","volume":"42","author":"Chandran","year":"2013","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.nano.2015.02.015_bb0015","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archderm.139.7.869","article-title":"The nonrandom distribution of facial hemangiomas","volume":"139","author":"Waner","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.nano.2015.02.015_bb0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1525-1470.1997.tb00232.x","article-title":"Superficial hemangiomas: associations and management","volume":"14","author":"Enjolras","year":"1997","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.nano.2015.02.015_bb0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1525-1470.2005.00102.x","article-title":"Infantile hemangiomas: current knowledge, future directions. Proceeding of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA","volume":"22","author":"Frieden","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.nano.2015.02.015_bb0030","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolnol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2015.02.015_bb0035","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/archoto.2010.92","article-title":"Propranolol in the management of airway infantile hemangiomas","volume":"136","author":"Rosbe","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.nano.2015.02.015_bb0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jpeds.2010.04.003","article-title":"Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis","volume":"157","author":"Mazereeuw-Hautier","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.nano.2015.02.015_bb0045","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/jp.2011.28","article-title":"Use of propranolol for treatment of hemangiomas in PHACE syndrome","volume":"31","author":"Solomon","year":"2011","journal-title":"J Perinatol"},{"key":"10.1016\/j.nano.2015.02.015_bb0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000351557","article-title":"Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases","volume":"228","author":"Sagi","year":"2014","journal-title":"Dermatology"},{"key":"10.1016\/j.nano.2015.02.015_bb0055","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.2174\/138161208785740180","article-title":"Nanotechnology for nanomedicine and delivery of drugs","volume":"14","author":"Venugopal","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nano.2015.02.015_bb0060","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.nano.2015.02.015_bb0065","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.biomaterials.2013.12.004","article-title":"A hematoporphyrin-based delivery system for drug resistance reversal and tumor ablation","volume":"35","author":"Ren","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2015.02.015_bb0070","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.biomaterials.2013.10.034","article-title":"The effect of autophagy inhibitors on drug delivery using biodegradable polymer nanoparticles in cancer treatment","volume":"35","author":"Zhang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2015.02.015_bb0075","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2165\/00128071-200304110-00003","article-title":"Optimal treatment of vascular birthmarks","volume":"4","author":"Werner","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.nano.2015.02.015_bb0080","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1525-1470.2006.00216.x","article-title":"How to measure a growing hemangioma and assess response to therapy","volume":"23","author":"Tansg","year":"2006","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.nano.2015.02.015_bb0085","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaad.2004.04.022","article-title":"Treatment of infantile haemangiomas with short-term application of imiquimod 5% cream","volume":"51","author":"Welsh","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.nano.2015.02.015_bb0090","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jpedsurg.2011.01.012","article-title":"Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas","volume":"46","author":"Kim","year":"2011","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.nano.2015.02.015_bb0095","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/lary.20633","article-title":"Propranolol for airway hemangiomas: case report of novel treatment","volume":"119","author":"Buckmiller","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.nano.2015.02.015_bb0100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1542\/peds.2012-1691","article-title":"Initiation and use of propranolol for infantile hemangioma: report of a consensus conference","volume":"131","author":"Drolet","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.nano.2015.02.015_bb0105","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jaad.2012.03.009","article-title":"Topical propranolol for treatment of superficial infantile hemangiomas","volume":"67","author":"Xu","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.nano.2015.02.015_bb0110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1525-1470.2011.01615.x","article-title":"Topical propranolol therapy for infantile hemangiomas","volume":"29","author":"Kunzi-Rapp","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.nano.2015.02.015_bb0115","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.annder.2013.04.085","article-title":"Rapid regression of infantile haemangioma with 2% propranolol ointment","volume":"140","author":"Mouhari-Toure","year":"2013","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.nano.2015.02.015_bb0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/jop.2011.0055","article-title":"Distribution of propranolol in periocular tissues: a comparison of topical and systemic administration","volume":"27","author":"Hao","year":"2011","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.nano.2015.02.015_bb0125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/pde.12175","article-title":"Failure of intralesional propranolol in infantile hemangiomas","volume":"31","author":"Torres-Pradilla","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.nano.2015.02.015_bb0130","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.taap.2012.10.014","article-title":"Superparamagnetic iron oxide polyacrylic acid coated gamma-Fe2O3 nanoparticles do not affect kidney function but cause acute effect on the cardiovascular function in healthy mice","volume":"266","author":"Iversen","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.nano.2015.02.015_bb0135","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejpb.2014.02.001","article-title":"Injected nanoparticles: the combination of experimental systems to assess cardiovascular adverse effects","volume":"87","author":"Vlasova","year":"2014","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2015.02.015_bb0140","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-4632.2011.05441.x","article-title":"Rapid complete regression of an early infantile hemangioma with topical timolol gel","volume":"53","author":"Semkova","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.nano.2015.02.015_bb0145","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3892\/etm.2013.1176","article-title":"Treatment of superficial infantile hemangiomas with timolol: evaluation of short-term efficacy and safety in infants","volume":"6","author":"Yu","year":"2013","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.nano.2015.02.015_bb0150","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s11095-012-0928-9","article-title":"Evaluation of skin permeation of \u03b2-blockers for topical drug delivery","volume":"30","author":"Chantasart","year":"2013","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2015.02.015_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(01)00731-1","article-title":"Skin, the final frontier","volume":"224","author":"Hadgraft","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2015.02.015_bb0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/117739280700200002","article-title":"Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications","volume":"2","author":"Guterres","year":"2007","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.nano.2015.02.015_bb0165","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.colsurfb.2011.08.004","article-title":"Enhanced transdermal delivery of indomethacin-loaded PLGA nanoparticles by iontophoresis","volume":"88","author":"Tomoda","year":"2011","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2015.02.015_bb0170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.colsurfb.2012.04.002","article-title":"Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis","volume":"97","author":"Tomoda","year":"2012","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.nano.2015.02.015_bb0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.colsurfb.2011.11.016","article-title":"Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo","volume":"92","author":"Tomoda","year":"2012","journal-title":"Colloids Surf B"},{"key":"10.1016\/j.nano.2015.02.015_bb0180","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.addr.2008.08.002","article-title":"Hydrogel nanoparticles in drug delivery","volume":"60","author":"Hamidi","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2015.02.015_bb0185","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1016\/j.biomaterials.2007.07.044","article-title":"Hydrogel biomaterials: a smart future?","volume":"28","author":"Kopecek","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2015.02.015_bb0190","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0190-9622(97)70183-X","article-title":"Guidelines of care for hemangiomas of infancy","volume":"37","author":"Frieden","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.nano.2015.02.015_bb0195","first-page":"130","article-title":"Oral propranolol for treatment of pediatric capillary hemangiomas","volume":"7","author":"Aletaha","year":"2012","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.nano.2015.02.015_bb0200","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.annder.2008.10.006","article-title":"Efficacy of beta-blockers in infantile haemangiomas: the physiopathological significance and therapeutic consequences","volume":"135","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.nano.2015.02.015_bb0205","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1525-1470.2009.00975.x","article-title":"Propranolol treatment for hemangioma of infancy: risks and recommendations","volume":"26","author":"Lawley","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.nano.2015.02.015_bb0210","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bjps.2010.06.010","article-title":"Low-dose propranolol for infantile haemangioma","volume":"64","author":"Tan","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.nano.2015.02.015_bb0215","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1542\/peds.2008-3458","article-title":"Propranolol for severe of periocular capillary haemangiomas","volume":"124","author":"Sans","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.nano.2015.02.015_bb0220","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archdermatol.2010.158","article-title":"Hypoglycemia in children taking propranolol for the treatment of infantile haemangioma","volume":"146","author":"Holland","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.nano.2015.02.015_bb0225","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1601-0825.2010.01661.x","article-title":"Diagnosis and management of haemangiomas and vascular malformations of the head and neck","volume":"16","author":"Buckmiller","year":"2010","journal-title":"Oral Dis"},{"key":"10.1016\/j.nano.2015.02.015_bb0230","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jemermed.2003.11.015","article-title":"Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers","volume":"26","author":"Love","year":"2004","journal-title":"J Emerg Med"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963415000659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963415000659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T21:35:01Z","timestamp":1691530501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963415000659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1549963415000659"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2015.02.015","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel topical nano-propranolol for treatment of infantile hemangiomas","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2015.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}